ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 227 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q3 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,336,313 | +2.8% | 245,195 | +26.6% | 0.01% | +16.7% |
Q2 2023 | $1,299,948 | -56.3% | 193,733 | -42.4% | 0.01% | -60.0% |
Q1 2023 | $2,971,887 | -4.6% | 336,567 | -17.4% | 0.02% | -11.8% |
Q4 2022 | $3,114,324 | +45.0% | 407,634 | +35.1% | 0.02% | +41.7% |
Q3 2022 | $2,148,000 | +23.4% | 301,754 | +40.2% | 0.01% | +33.3% |
Q2 2022 | $1,741,000 | +48.5% | 215,258 | +154.9% | 0.01% | +28.6% |
Q1 2022 | $1,172,000 | +32.3% | 84,456 | +167.3% | 0.01% | +40.0% |
Q4 2021 | $886,000 | +266.1% | 31,593 | +343.8% | 0.01% | +150.0% |
Q3 2021 | $242,000 | -94.5% | 7,118 | -93.4% | 0.00% | -93.5% |
Q2 2021 | $4,412,000 | -18.1% | 107,977 | -19.3% | 0.03% | -20.5% |
Q1 2021 | $5,387,000 | -59.2% | 133,794 | -40.1% | 0.04% | -64.9% |
Q4 2020 | $13,206,000 | +172.9% | 223,339 | +124.5% | 0.11% | +177.5% |
Q3 2020 | $4,839,000 | +356.5% | 99,503 | +354.4% | 0.04% | +233.3% |
Q2 2020 | $1,060,000 | – | 21,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 3,030,434 | $20,334,212 | 13.72% |
BERYLSON CAPITAL PARTNERS, LLC | 228,000 | $1,529,880 | 4.32% |
Eagle Health Investments LP | 1,214,860 | $8,151,711 | 1.52% |
Matrix Capital Management Company, LP | 11,572,590 | $77,652,079 | 0.90% |
Triatomic Management LP | 121,166 | $813,024 | 0.83% |
VIKING GLOBAL INVESTORS LP | 29,993,708 | $201,257,781 | 0.82% |
Aristotle Atlantic Partners, LLC | 3,104,961 | $20,834,288 | 0.78% |
Pier Capital, LLC | 737,589 | $4,949,222 | 0.71% |
ARK Investment Management | 10,453,752 | $70,144,675 | 0.46% |
Nikko Asset Management Americas, Inc. | 6,384,047 | $42,773,115 | 0.45% |